The impact of medication shortages on paediatric care: A retrospective impact analysis
British Journal of Clinical Pharmacology · 12.08.2026
DOI: 10.1002/bcp.70730 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 12.08.2026. Verfasst von Maaike Johanna Rutten-van Kranenburg und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, the Netherlands. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
Medication shortages are a growing global concern, with potentially greater consequences in paediatric patients because of the limited availability of safe, evidence‐based and appropriately formulated medication. This study aimed to evaluate the impact of medication shortages on paediatric patients by assessing the suitability and safety of alternative treatment options.
Methods
A semi‐quantitative assessment was conducted in a tertiary care paediatric hospital in the Netherlands of medication shortages occurring between January 2022 and June 2023. Alternative treatments were evaluated using a scoring methodology based on clinical efficacy, safety profile, medication safety aspects, disease severity, patient susceptibility, number of patients and cost implications. Each component was assigned an impact score ranging from 1 ( low ) to 3 ( high ). The overall impact score for each medication shortage was calculated by multiplying individual component scores.
Results
Thirty‐two medication shortages were analysed, with 15 classified as high impact and 7 as moderate impact. Anti‐infective and central nervous system medication were most frequently affected. Patient susceptibility and the number of patients had the greatest influence on the total impact score of a shortage. Identified challenges included variations in dosing regimens, differing dosage forms, the presence of undesirable excipients and limited evidence for use in paediatric patients.
Conclusions
Medication shortages can significantly affect paediatric patients and healthcare professionals, potentially impeding the delivery of optimal care. This systematic impact assessment emphasizes the need for further attention to paediatric‐specific safety and efficacy considerations in policy development and strategies to mitigate the effects of medication shortages.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, the Netherlands.
- Department of Pediatric and Neonatal Intensive Care, Division of Neonatology, Erasmus University Medical Centre - Sophia Children's Hospital, Rotterdam, the Netherlands.
- Department of Outpatient Pharmacy, Erasmus University Medical Centre, Rotterdam, the Netherlands.
ORCID-Profile: Maaike Johanna Rutten-van Kranenburg, Elisabeth Johanna Ruijgrok, Robert Bernard Flint
Zitieren
APA
Rutten-van Kranenburg, M. J., van Rijn, L. C., Ruijgrok, E. J., Simons, S. H. P., Witjes, B. C. M., Brugma, J. C., & Flint, R. B. (2026). The impact of medication shortages on paediatric care: A retrospective impact analysis. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70730
Vancouver
Rutten-van Kranenburg MJ, van Rijn LC, Ruijgrok EJ, Simons SHP, Witjes BCM, Brugma JC, et al. The impact of medication shortages on paediatric care: A retrospective impact analysis. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70730
BibTeX
@article{RuttenvanKranenburg2026,
author = {Rutten-van Kranenburg, Maaike Johanna and van Rijn, Laurens Christiaan and Ruijgrok, Elisabeth Johanna and Simons, Sinno Henricus Paulus and Witjes, Brigitta Carolina Maria and Brugma, Jan-Dietert Christoffer and Flint, Robert Bernard},
title = {The impact of medication shortages on paediatric care: A retrospective impact analysis},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70730}
}
EUVIMED